KIDNEY TRANSPLANT RECIPIENTS
Clinical trials for KIDNEY TRANSPLANT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT RECIPIENTS trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Transplant patients get new hope for COVID-19 defense
Disease control CompletedThis study tested a method to help kidney and liver transplant patients get better protection from COVID-19. Researchers gave 48 transplant recipients a booster shot and randomly assigned half to also temporarily lower their anti-rejection medications. The goal was to see if this…
Matched conditions: KIDNEY TRANSPLANT RECIPIENTS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Once-Daily pill may ease transplant Patients' drug side effects
Symptom relief CompletedThis study tested whether taking a once-daily, extended-release version of the anti-rejection drug tacrolimus causes fewer side effects and is easier to stick with than the standard twice-daily version. Researchers enrolled 261 adult kidney transplant recipients to compare sympto…
Matched conditions: KIDNEY TRANSPLANT RECIPIENTS
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 25, 2026 14:09 UTC
-
Doctors Double-Check their tools to better understand transplant rejection
Knowledge-focused CompletedThis study aimed to check how reliable certain lab tests are for measuring immune cells in people who have had or will have a kidney transplant. Researchers took two small bone marrow samples from 288 donors and recipients to see if the test results were consistent. The goal was …
Matched conditions: KIDNEY TRANSPLANT RECIPIENTS
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC